sunny.png
Sunday January 23rd, 2022 10:58AM

Sonoma Pharmaceuticals and Dyamed Biotech Announce Expanded Long-Term Partnership for New Territories and Products in Southeast Asia

By The Associated Press

WOODSTOCK, Ga.--(BUSINESS WIRE)--Nov 9, 2021--

Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions and disinfectant use, and its long-time partner, Dyamed Biotech Pte Ltd., announce a renewed and expanded long-term partnership for Singapore, Malaysia, Indonesia and Thailand for multiple indications using Sonoma’s patented Microcyn® Technology.

Dyamed Biotech Pte Ltd., one of Sonoma’s first international partners, successfully commercializes Dermacyn® Wound Care, Dermacyn® Scarless for Scar Reduction, and Dermacyn® Ezyma Spray for itch relief associated with atopic dermatitis. Dyamed expects to launch Ocucyn® Eye Care and Oracyn® Oral Care in 2022. The Dermacyn® line of products are widely used at many hospitals throughout Singapore and Malaysia.

“We are so pleased with the performance of the Dermacyn® line of products which have helped provide modern wound care for both acute and chronic wounds in our hospitals and health care facilities for many years. With the additional indications using the patented Microcyn® Technology for scar reduction and atopic dermatitis treatment, we have had many patients see positive results,” said Dyamed Biotech Pte Ltd., CEO Theodore Tan.

“In addition, we look forward to the next year as we expand the Dermacyn® line of products for both eye and oral care in pharmacies and hospitals throughout Southeast Asia,” Mr. Tan added.

Bruce Thornton, Chief Operating Officer of Sonoma Pharmaceuticals said, “Dyamed has been a valued partner since 2004 and we are excited to support the next chapter of this special partnership. With the addition of the new territories of Indonesia and Thailand and new oral and eye care products, we expect Dyamed to expand its reach into both hospitals and pharmacy care. We are continuously seeking to expand our network of international distributors with quality partners like Dyamed to increase the reach of Sonoma products worldwide.”

Dyamed Biotech was established in 1998 to distribute quality medical diagnostic devices in Southeast Asia. The company is headquartered in Singapore and has a branch office in Malaysia. Dyamed Biotech distributes to public and private hospitals, clinics and pharmacies in Southeast Asia. Please contact us at +65 6848 1028 or visit our website at .

Sonoma Pharmaceuticals is a global healthcare leader for developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, animal health care, eye care, nasal care, oral care, disinfectant use and dermatological conditions. The company’s products reduce infections, itch, pain, scarring and harmful inflammatory responses in a safe and effective manner. In-vitro and clinical studies of hypochlorous acid (HOCl) show it to have impressive antipruritic, antimicrobial, antiviral and anti-inflammatory properties. Sonoma’s stabilized HOCl immediately relieves itch and pain, kills pathogens and breaks down biofilm, does not sting or irritate skin and oxygenates the cells in the area treated assisting the body in its natural healing process. The company’s products are sold either directly or via partners in 54 countries worldwide and the company actively seeks new distribution partners. The company’s principal office is in Woodstock, Georgia, with manufacturing operations in Latin America. European marketing and sales are headquartered in Roermond, Netherlands. More information can be found at . For partnership opportunities, please contact .

Except for historical information herein, matters set forth in this press release are forward-looking within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including statements about the commercial and technology progress and future financial performance of Sonoma Pharmaceuticals, Inc. and its subsidiaries (the “company”). These forward-looking statements are identified by the use of words such as “continue,” “develop” and “expand,” among others. Forward-looking statements in this press release are subject to certain risks and uncertainties inherent in the company’s business that could cause actual results to vary, including such risks that regulatory clinical and guideline developments may change, scientific data may not be sufficient to meet regulatory standards or receipt of required regulatory clearances or approvals, clinical results may not be replicated in actual patient settings, protection offered by the company’s patents and patent applications may be challenged, invalidated or circumvented by its competitors, the available market for the company’s products will not be as large as expected, the company’s products will not be able to penetrate one or more targeted markets, revenues will not be sufficient to meet the company’s cash needs, fund further development, as well as uncertainties relative to the COVID-19 pandemic and economic development, varying product formulations and a multitude of diverse regulatory and marketing requirements in different countries and municipalities, and other risks detailed from time to time in the company’s filings with the Securities and Exchange Commission. The company disclaims any obligation to update these forward-looking statements, except as required by law.

View source version on businesswire.com:

CONTACT: Media and Investor Contact:

Sonoma Pharmaceuticals, Inc.

[email protected]

KEYWORD: SINGAPORE NORTH AMERICA ASIA PACIFIC CANADA UNITED STATES THAILAND MALAYSIA INDONESIA GEORGIA

INDUSTRY KEYWORD: INFECTIOUS DISEASES OTHER HEALTH HEALTH PHARMACEUTICAL MEDICAL SUPPLIES

SOURCE: Sonoma Pharmaceuticals, Inc.

Copyright Business Wire 2021.

PUB: 11/09/2021 07:00 AM/DISC: 11/09/2021 07:02 AM

http://www.businesswire.com/news/home/20211109005550/en

  • Associated Categories: Associated Press (AP), AP Business, AP Business - Corporate News, AP Online - Georgia News, AP Business Wire - Georgia, AP Business - Industries, AP Business - Health Care
© Copyright 2022 AccessWDUN.com
All rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.
Man with knife threatens passers-by in Norway, is shot dead
A man reportedly armed with a knife has threatened passers-by on the streets of the Norwegian capital, Oslo, before being shot dead by police
7:26AM ( 11 minutes ago )
US Holocaust Museum says China boosting Uyghur repression
The U.S. Holocaust Memorial Museum says it has compiled evidence of increasing government repression against Uyghur Muslims in China's western Xinjiang region
7:03AM ( 34 minutes ago )
Climate talks struggle with gap between rich, poor nations
It's time for high-level diplomats to start working to settle the several key outstanding issues in international climate talks in Glasgow, Scotland
7:00AM ( 37 minutes ago )
Associated Press (AP)
Taiwan's TSMC to build first chip plant in Japan amid crunch
Japanese electronics maker Sony and TSMC of Taiwan say they are jointly building a computer chip plant in Japan with an initial investment of $7 billion
6:30AM ( 1 hour ago )
The Latest: Ocasio-Cortez advises climate activists to push
U.S. Rep. Alexandria Ocasio-Cortez says she hopes to see the United States reestablish itself as a world leader in the fight against global warming
6:12AM ( 1 hour ago )
The AP Interview: Facebook whistleblower fears the metaverse
Facebook whistleblower Frances Haugen says she fears the impact of the metaverse that the social media giant has rebranded to focus on delivering
5:52AM ( 1 hour ago )
AP Business
Asian stock markets mixed after Wall St hits record again
Asian stock markets are mixed after Wall Street rose to a record for an eighth day
12:12AM ( 7 hours ago )
Musk: I'll sell 10% of Tesla stock based on Twitter poll
Tesla shares closed Monday down nearly 5% after CEO Elon Musk said he would sell 10% of his holdings in the electric car maker — more than $20 billion worth by most calculations — based on the results of a poll he conducted on Twitter over the weekend
5:15PM ( 14 hours ago )
Another day, another record on Wall Street as stocks inch up
Stocks notched some modest gains on Wall Street Monday, enough to mark more record highs for major U.S. indexes
4:32PM ( 15 hours ago )
AP Business - Corporate News
Curry scores 50 points to go with 10 assists in Warriors win
Stephen Curry scored an NBA season-high 50 points with nine 3-pointers and added 10 assists and seven rebounds, almost single-handedly leading the Golden State Warriors past the Atlanta Hawks 127-113
1:55AM ( 5 hours ago )
Government: Vaccine rule should remain while cases play out
The Biden administration is framing its vaccine mandate for private employers in life-and-death terms in a legal filing that sought to get the requirement back on track after it was halted by a federal court
7:29PM ( 12 hours ago )
Feds propose threatened status for alligator snapping turtle
The U.S. Fish and Wildlife Service is proposing threatened status for alligator snapping turtles -- huge, spike-shelled beasts that lurk at the bottom of lakes, luring prey to their mouths by extending a wormlike lure
5:27PM ( 14 hours ago )
AP Online - Georgia News
AP Business Wire - Georgia
Railroads fight with unions in court over vaccine mandates
Another major railroad has gone to court to determine whether it has the authority to require all its employees to get vaccinated against the coronavirus
6:49PM ( 12 hours ago )
Vaccine proof required in LA as strict mandate takes effect
People going to shopping malls, theaters, gyms or nail salons in Los Angeles must now verify that they are vaccinated against COVID-19
6:01PM ( 13 hours ago )
Latest exit from Fed's board gives Biden three slots to fill
Randal Quarles announced Monday that he will resign from the Federal Reserve’s Board of Governors at the end of the year after completing a four-year term as the central bank’s top bank regulator, opening up another vacancy on the Fed’s influential board for President Joe Biden to fill
4:33PM ( 15 hours ago )
AP Business - Industries
Lawsuits over workplace vaccine rule focus on states' rights
The attorneys general of 27 states have filed federal lawsuits challenging a vaccine mandate for employers issued by the Biden administration
9:43PM ( 3 days ago )
House Dems delay huge social bill, plan infrastructure vote
Top Democrats have abruptly postponed an expected House vote on their 10-year, $1.85 trillion social and environment measure
8:15PM ( 3 days ago )
Pfizer says COVID-19 pill cut hospital, death risk by 90%
Pfizer says its experimental pill for COVID-19 cut rates of hospitalization and death by nearly 90% among patients with mild-to-moderate infections
5:24PM ( 3 days ago )
AP Business - Health Care
Man with knife threatens passers-by in Norway, is shot dead
A man reportedly armed with a knife has threatened passers-by on the streets of the Norwegian capital, Oslo, before being shot dead by police
7:26AM ( 11 minutes ago )
US Holocaust Museum says China boosting Uyghur repression
The U.S. Holocaust Memorial Museum says it has compiled evidence of increasing government repression against Uyghur Muslims in China's western Xinjiang region
7:03AM ( 35 minutes ago )
Climate talks struggle with gap between rich, poor nations
It's time for high-level diplomats to start working to settle the several key outstanding issues in international climate talks in Glasgow, Scotland
7:00AM ( 38 minutes ago )
SpaceX returns 4 astronauts to Earth, ending 200-day flight
Four astronauts are back on Earth after a 200-day space station mission
6:55AM ( 43 minutes ago )
US VP Harris arrives in Paris for 4-day fence-mending trip
U.S. Vice President Kamala Harris has landed in Paris at the start of a four-day visit and charm offensive aimed at shoring up the U.S. relationship with France, America’s oldest ally
6:52AM ( 45 minutes ago )